✦ LIBER ✦

Radiotherapy Combined with Gemcitabine and Oxaliplatin in Pancreatic Cancer Cells

✍ Scribed by Morgan, Meredith A.; Meirovitz, Amichay; Davis, Mary A.; Kollar, Laura E.; Hassan, Maria C.; Lawrence, Theodore S.

Book ID: 122177729
Publisher: Elsevier
Year: 2008
Tongue: English
Weight: 441 KB
Volume: 1
Category: Article
ISSN: 1936-5233
DOI: 10.1593/tlo.07106

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination therapy with Oxaliplatin + G

Combination therapy with Oxaliplatin + Gemcitabine in advanced pancreatic cancer

✍ R. Klapdor; J. Martini-Svendsen; R. Seutter; C. Fenner 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Gemcitabine and oxaliplatin combination

Gemcitabine and oxaliplatin combination chemotherapy in 30 patients with advanced pancreatic carcinoma

✍ Fan Zhao; Jianhua Miao; Di Zhao; Shubo Chen 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 191 KB

Toxicity study of gemcitabine, oxaliplat

Toxicity study of gemcitabine, oxaliplatin, and bevacizumab, followed by 5-fluorouracil, oxaliplatin, bevacizumab, and radiotherapy, in patients with locally advanced pancreatic cancer

✍ Davendra P. S. Sohal, James M. Metz, Weijing Sun… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 314 KB

Gemcitabine–radiotherapy in patients wit

Gemcitabine–radiotherapy in patients with locally advanced pancreatic cancer

✍ S.M. de Lange; C.J. van Groeningen; O.W.M. Meijer; M.A. Cuesta; J.A. Langendijk; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Combination of salinomycin and gemcitabi

Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells

✍ Guan-Nan Zhang; Yi Liang; Ling-Jun Zhou; Shu-Peng Chen; Ge Chen; Tai-Ping Zhang; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 930 KB

Gemcitabine and platinum combinations in

Gemcitabine and platinum combinations in pancreatic cancer

✍ Philip Agop Philip 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Progress in the treatment of pancreatic cancer in the past several decades has been very modest. Several new agents with activity against this disease have been identified. Of these, gemcitabine appears to be the most promising when used in combination with other drugs. Gemcitabine and cisplatin com